Microbot Medical Inc. (MBOT): Price and Financial Metrics

Microbot Medical Inc. (MBOT): $0.87

0.03 (-2.81%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

MBOT Price/Volume Stats

Current price $0.87 52-week high $4.37
Prev. close $0.89 52-week low $0.86
Day low $0.86 Volume 94,800
Day high $0.89 Avg. volume 124,283
50-day MA $1.19 Dividend yield N/A
200-day MA $1.54 Market Cap 12.46M

MBOT Stock Price Chart Interactive Chart >


Microbot Medical Inc. (MBOT) Company Bio


Microbot Medical Inc. operates as a medical device company. The Company specializes in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Microbot Medical offers its services in the United States.


MBOT Latest News Stream


Event/Time News Detail
Loading, please wait...

MBOT Latest Social Stream


Loading social stream, please wait...

View Full MBOT Social Stream

Latest MBOT News From Around the Web

Below are the latest news stories about MICROBOT MEDICAL INC that investors may wish to consider to help them evaluate MBOT as an investment opportunity.

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical studyBRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels of planning, controlling, monitoring, and reporting, using a porcine model. As previously a

Yahoo | December 28, 2023

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatmentsBRAINTREE, Mass., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced it has entered into a collaboration agreement with Corewell Health™. The objective of the collaboration, which will take place in multiple phases, is to

Yahoo | December 14, 2023

3 Stocks at the Forefront of Medical Robotics

Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy.

Josh Enomoto on InvestorPlace | December 10, 2023

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

The final histopathology and lab report supplements previous positive Company findings. The results of the study will support the Company’s IDE submission to the FDA to commence its human clinical study. BRAINTREE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required levels o

Yahoo | December 7, 2023

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

The former Senior Medical Director for the Peripheral Interventions Division at Boston Scientific Corporation joins the Company as it transitions to the clinical and regulatory phase.BRAINTREE, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced the appointment of Dr. Juan Diaz-Cartelle as its new Chief Medical Officer (CMO), effective December 1, 2023. The hiring of Dr. Diaz-Car

Yahoo | November 21, 2023

Read More 'MBOT' Stories Here

MBOT Price Returns

1-mo -26.89%
3-mo -33.08%
6-mo -30.95%
1-year -46.95%
3-year -88.76%
5-year -88.63%
YTD -46.95%
2023 -45.51%
2022 -59.87%
2021 8.85%
2020 -32.25%
2019 491.28%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!